E. coli Beta-Lactamase Production Yield Optimization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing beta-lactamases in E. coli cells result in low yields, limiting their therapeutic application for maintaining intestinal microbiome balance and preventing antibiotic-associated disruptions.

Innovation Solution

A method involving transforming E. coli cells with a vector encoding the beta-lactamase polypeptide, inducing its expression in the cytoplasm, and recovering it from soluble fractions, achieving high yields of up to 50 grams per liter of culture.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If current methods are used for producing beta-lactamases in E. coli cells, then the production process is simple, but the yield is low

Engineering Contradiction:
Improvebeta-lactamase production yieldVSAvoidproduction method complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent applies parameter changes by optimizing multiple cultivation parameters including induction temperature (16-25°C), induction time (18-48 hours), pH (6.8-7.5), and aeration rates (0.5-2.0 vvm) to achieve high beta-lactamase yields of 50 grams per liter or more, transforming a low-yield process into a high-yield production system through systematic parameter optimization

Inventive Principle:
Principle #35Parameter changes

2Reliability

If beta-lactamase production is increased for therapeutic application, then the therapeutic potential improves, but the production cost and complexity increase

Engineering Contradiction:
Improvetherapeutic effectivenessVSAvoidproduction feasibility
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent employs self-service principles by utilizing the E. coli cell's own cellular machinery and metabolic pathways for beta-lactamase production. The system uses endogenous resources including amino acids, energy (ATP), and protein synthesis mechanisms to produce the enzyme, eliminating the need for complex external support systems or specialized production infrastructure

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent optimizes cultivation parameters including maintaining pH between 6.8-7.5, temperature control at 16-25°C during induction, dissolved oxygen levels (20-80% air saturation), and extended induction periods (18-48 hours) to achieve high yields of 50 grams per liter or more, making therapeutic production economically viable

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly increases the production yield of beta-lactamases, offering improved therapeutic potential for protecting the intestinal microbiome and mitigating antibiotic-related disruptions.

Implementation Method 1

providing a host E. coli cell transformed with a vector comprising a sequence encoding the beta-lactamase polypeptide

Methodology Applied
Scientific EffectGenetic transformation:

Implementation Method 2

The E. coli cell is cultured to induce expression of the beta-lactamase in the cytoplasm

Methodology Applied
Scientific EffectGene expression:

Implementation Method 3

beta-lactamases are able to efficiently catalyze the irreversible hydrolysis of the amide bond of the beta-lactam ring resulting in biologically inactive product(s)

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Data Source

PatentUS11981899B2<i>E. coli</i>-based production of beta-lactamase
Publication Date: 2024.05.14 THERIVA BIOLOGICS INC
  • US11981899B2 patent drawing
  • US11981899B2 patent drawing
  • US11981899B2 patent drawing

AI summary

The invention relates to, in part, improved methods for the production of beta-lactamase using Escherichia coli (E. coli) cells. High yield production of beta-lactamase is achieved using methods of the invention.